All In MedTech

Device Trial Radar · NCT01325792

Open Complex Ventral Incisional Hernia Repair Using Biosynthetic Material for Midline Fascial Closure Reinforcement

Prospective, Multicenter, Observational Study Evaluate Single-Staged Open Complex Ventral Incisional Hernia Repair Using a Biosynthetic Material for Midline Fascial Closure Reinforcement

Last checked: Nov 19, 2026Latest source record: Dec 24, 2015 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

104

Actual

Start

Feb 2011

Primary completion

Dec 2014

Study completion Dec 2014

Sponsor

Lead sponsor
W.L.Gore & AssociatesNot on our public-company list
Sponsor type
Industry
First posted
Mar 30, 2011

More device trials from this sponsor

Design

Study type
Observational
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Prospective, multicenter, observational study to evaluate performance of GORE® BIO-A® Tissue Reinforcement when used to reinforce midline fascial closure in single-staged open complex ventral incisional hernia repair.

Conditions

  • Ventral Incisional Hernia

Interventions

  • GORE® BIO-A® Tissue ReinforcementDevice

    Retrorectus or intraperitoneal placement of device to reinforce the midline fascial closure after single-staged open complex ventral incisional hernia repair of primary or recurrent anterior abdominal wall hernia.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Hernia Recurrence RateTime frame: at about 24 months

Locations

9 sites in 2 countries. Site status is shown where the registry gives one.

  • UCSD Department of Surgery

    San Diego, California

  • Indiana University

    Indianapolis, Indiana

  • Washington University

    St Louis, Missouri

6 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.